These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16715675)

  • 1. Preliminary study of correction of original metal artifacts due to 1-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy.
    Takahashi Y; Mori S; Kozuka T; Gomi K; Nose T; Tahara T; Oguchi M; Yamashita T
    Radiat Med; 2006 Feb; 24(2):133-8. PubMed ID: 16715675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-energy metal artifact reduction in postimplant computed tomography for I-125 prostate brachytherapy: Impact on seed identification.
    Shiraishi Y; Yamada Y; Tanaka T; Eriguchi T; Nishimura S; Yoshida K; Hanada T; Ohashi T; Shigematsu N; Jinzaki M
    Brachytherapy; 2016; 15(6):768-773. PubMed ID: 27592130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral CT with monochromatic imaging and metal artifacts reduction software for artifacts reduction of ¹²⁵I radioactive seeds in liver brachytherapy.
    Yang Q; Peng S; Wu J; Ban X; He M; Xie C; Zhang R
    Jpn J Radiol; 2015 Nov; 33(11):694-705. PubMed ID: 26456321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients.
    Nosrati R; Song WY; Wronski M; Pejović-Milić A; Morton G; Stanisz GJ
    Brachytherapy; 2019; 18(6):863-874. PubMed ID: 31337542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of virtual patient models for permanent implant brachytherapy Monte Carlo dose calculations: interdependence of CT image artifact mitigation and tissue assignment.
    Miksys N; Xu C; Beaulieu L; Thomson RM
    Phys Med Biol; 2015 Aug; 60(15):6039-62. PubMed ID: 26216174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy.
    Sutherland JG; Miksys N; Furutani KM; Thomson RM
    Med Phys; 2014 Jan; 41(1):011712. PubMed ID: 24387504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).
    Nosrati R; Soliman A; Safigholi H; Hashemi M; Wronski M; Morton G; Pejović-Milić A; Stanisz G; Song WY
    Radiother Oncol; 2018 Dec; 129(3):540-547. PubMed ID: 30243670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformable registration of x ray and MRI for postimplant dosimetry in low dose rate prostate brachytherapy.
    Hrinivich WT; Park S; Le Y; Song DY; Lee J
    Med Phys; 2019 Sep; 46(9):3961-3973. PubMed ID: 31215042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
    Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
    J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in MR-only seed localization for postimplant dosimetry in permanent prostate brachytherapy.
    Zijlstra F; Moerland MA; van der Voort van Zyp JRN; Noteboom JL; Viergever MA; Seevinck PR
    Med Phys; 2017 Oct; 44(10):5051-5060. PubMed ID: 28777451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the visibility of a new thinner ¹²⁵I radioactive source for permanent prostate brachytherapy.
    Roberts G; Al-Qaisieh B; Bownes P
    Brachytherapy; 2012; 11(6):460-7. PubMed ID: 22436518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algorithm for efficient metal artifact reductions in permanent seed.
    Xu C; Verhaegen F; Laurendeau D; Enger SA; Beaulieu L
    Med Phys; 2011 Jan; 38(1):47-56. PubMed ID: 21361174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BrachyView: Reconstruction of seed positions and volume of an LDR prostate brachytherapy patient plan using a baseline subtraction algorithm.
    Brennen T; Cutajar DL; Alnaghy S; Bucci J; Bece A; Enari K; Favoino M; Carriero F; Tartaglia M; Galli L; Lerch M; Rosenfeld AB; Petasecca M
    Phys Med; 2019 Oct; 66():66-76. PubMed ID: 31563727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EM-enhanced US-based seed detection for prostate brachytherapy.
    Dehghan E; Bharat S; Kung C; Bonillas A; Beaulieu L; Pouliot J; Kruecker J
    Med Phys; 2018 Jun; 45(6):2357-2368. PubMed ID: 29604086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
    Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.